Skip to content

Spider toxin analogue may help relieve pain

New research from the British Journal of Pharmacology (BJP) suggests that a compound based on a spider toxin may be effective for treating pain.

Experiments conducted in rats revealed that the compound, called PnPP-19, provided pain relief most likely by acting on receptors in the nervous system that also bind opioids and cannabis (or marijuana). Interestingly, PnPP-19 is also being studied as a drug candidate to treat erectile dysfunction.

“Our findings reveal at least part of the mechanism of action underlying the pain relieving effects induced by PnPP-19,” said Dr. Maria de Lima, lead author of the BJP study. “They also may contribute to the consideration of PnPP-19 as a potential lead compound for the development of new drug candidates to treat pain.”

Read the full article.

Latest news & activity

Scholarship/studentship

The British Pharmacological Society is delighted to launch its PhD Funding Programme for awards in 2027.

The programme includes both the AJ Clark…

Prizes and awards

The Federation of European Pharmacological Societies (EPHAR) has opened applications for its Young Investigators Award 2026. Two awards of €1,000 each…

Prizes and awards

The British Pharmacological Society (BPS) recognises the contributions to pharmacology made by our members and increases its impact on the discipline…